Industry / Bulgaria
Significant Growth For Drug Market
March 2008 | Industry NewsBMI has revised its forecasts for the Bulgarian drug market after new figures were released by IMS Health. We now believe the market reached a value of US$970mn in 2007 after growing by 12%. By 2012, total sales should reach US$1.76mn, representing 2.4% of GDP.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
